WASHINGTON — A bipartisan group of seven former FDA Commissioners are uniting to advocate for breaking the Food and Drug Administration out of the Department of Health and Human Services and making it an independent agency.

The idea is to make the FDA less vulnerable to political pressure, so it can focus instead on protecting public health. While FDA’s mission has always been politicized, the issue is particularly salient now given President Trump’s propensity for pressuring the agency to prioritize politically popular policies. Current commissioner Scott Gottlieb has been a good soldier for that effort, even implementing the Right to Try pathway that previous commissioners said would “create a dangerous precedent.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy